Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Understanding the value of points versus cash back helps you make smart financial choices. Compare both to see which is more beneficial.
28,655 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
As mortgage conditions shift in 2026, AI is helping real estate agents: make time, win leads, and coordinate loans mo...
The VIX slid as optimism about geopolitical peace and cheaper oil spurred a broad market rally. Analysts caution the ...
Google reopens mobile real estate listings in a growing pilot, delivering property pages, tour requests and agent con...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
State Street unveils a GENIUS-compliant money market fund designed for stablecoin issuers, offering regulated liquidi...
Apple appears to have sealed an early victory in the 2026 chip race, securing dominant access to the most advanced pr...
XRP continues to slide in March 2026 despite regulatory wins and Brazil expansion, with traders weighing macro risks,...
As markets wobble and political headwinds rise, a growing chorus argues that ceos have forgotten moderate. This piece...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...
Costco reported a sturdy quarterly performance, signaling continued strength in its membership model. The company spo...
June volatility has weighed on semiconductor stocks, but a window is emerging for selective buys. Here are three name...